FDA released the new draft guidance for Transdermal and Topical Delivery System (TDS) product development

On November 22, FDA released the new draft guidance for “Transdermal and Topical Delivery Systems (TDS) – Product Development and Quality Considerations”. This is a useful guide to help the industry to deal with the complexity of the transdermal delivery system or patch and the associated challenges related to product development.